Top

Published in:

01-11-2018 | Original Contributions

The Effect of the Bariatric Surgery Type on the Levothyroxine Dose of Morbidly Obese Hypothyroid Patients

Authors: Jorge Pedro, Filipe Cunha, Pedro Souteiro, João Sérgio Neves, Vanessa Guerreiro, Daniela Magalhães, Rita Bettencourt-Silva, Sofia Castro Oliveira, Maria Manuel Costa, Joana Queirós, Paula Freitas, Ana Varela, Davide Carvalho

Published in: Obesity Surgery | Issue 11/2018

Abstract

Background

Doubts exist about the effect of different bariatric surgery (BS) types on levothyroxine (Lt4) absorption. We compared Lt4 doses and their variation (ΔLt4) in patients with hypothyroidism that underwent malabsorptive (MS) or restrictive (RS) surgery and studied predictors of Lt4 dose change.

Methods

Retrospective study of morbidly obese hypothyroid patients submitted to BS. We compared RS (“sleeve” gastrectomy or adjustable gastric banding) with MS (Roux-en-Y gastric bypass) patients. We built a multivariable logistic regression and a linear regression model to study predictors of Lt4 dose changes and ΔLt4, respectively.

Results

Fifty-seven patients: 35 MS and 22 RS. Mean age 47 years; 7% men. Patients submitted to MS had lower BMI at 1 year than those submitted to RS. Lt4 dose remained unchanged in 61.4%, increased in 12.3%, and decreased in 26.3% of patients. Initial and 1-year Lt4 dose were not different between surgical groups. Relative Lt4 dose, but not absolute (p = 0.07), increased at 1 year (p < 0.001). Neither BS nor BMI variation were predictors of Lt4 dose variation. BMI variation was associated with relative Lt4 dose change independently of initial BMI and BS type: β (95%CI) − 0.03 (− 0.05; 0.00); p = 0.03.

Conclusions

There were no differences in Lt4 dose and its variation between restrictive and malabsorptive techniques 1 year after surgery. Malabsorptive procedures may not affect Lt4 absorption differently from restrictive ones. Bariatric surgery type was not predictive of Lt4 dose changes. BMI variation is associated with relative Lt4 dose (dose per weight) variation and its association was independent of bariatric surgery type.

Pi-Sunyer X. The medical risks of obesity. Postgrad Med. 2009;121(6):21–33. Available from: http://www.tandfonline.com/doi/full/10.3810/pgm.2009.11.2074 CrossRefPubMedPubMedCentral

Lubrano C, Mariani S, Badiali M, et al. Metabolic or bariatric surgery long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes. 2010;34(9):1404–14. Available from: https://doi.org/10.1038/ijo.2010.54 CrossRef

Kissler HJ, Settmacher U. Bariatric surgery to treat obesity. Semin Nephrol. 2013;33(1):75–89. Available from: https://doi.org/10.1016/j.semnephrol.2012.12.004 CrossRefPubMed

Altieri MS, Wright B, Peredo A, Pryor AD. Common weight loss procedures and their complications. Am J Emerg Med. 2017. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0735675717309580.

Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American association of clinical endocrinologists, the obesity society, and American society fo. Obesity. 2013;21(SUPPL. 1):159–91. Available from: https://doi.org/10.1016/j.soard.2012.12.010

Fierabracci P, Pinchera A, Martinelli S, et al. Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes. Obes Surg. 2011;21(1):54–60.CrossRefPubMed

Janković D, Wolf P, Anderwald C-H, et al. Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters. Obes Surg. 2012;22(1):62–9. Available from: http://link.springer.com/10.1007/s11695-011-0545-4 CrossRefPubMed

Ojomo KA, Schneider DF, Reiher AE, et al. Using BMI to predict optimal thyroid dosing following\n Thyroidectomy. 2013;216(3):454–60. https://doi.org/10.1016/j.jamcollsurg.2012.12.002.CrossRefPubMedPubMedCentral

Rubio IGS, Galrão AL, Santo MA, et al. Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery. Obes Surg. 2012;22(2):253–8.CrossRefPubMed

10.

Michalaki MA, Gkotsina MI, Mamali I, et al. Impaired pharmacokinetics of levothyroxine in severely obese volunteers. Thyroid. 2011;21(5):477–81. Available from: http://www.liebertonline.com/doi/abs/10.1089/thy.2010.0149 CrossRefPubMed

11.

Raftopoulos Y, Gagne DJ, Papasavas P, et al. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2004;14(4):509–13. https://doi.org/10.1381/096089204323013514.CrossRefPubMed

12.

Farwell AP. Clinical thyroidology for the public A publication of the American Thyroid Association among hypothyroid patients? A publication of the American Thyroid Association Thyroid Awareness Monthly Campaigns The ATA will be highlighting a distinct thyroid. Clin Thyroidol Public 2017;10(7):3–4.

13.

Gkotsina M, Michalaki M, Mamali I, et al. Improved levothyroxine pharmacokinetics after bariatric surgery. Thyroid. 2013;23(4):414–9. Available from: http://online.liebertpub.com/doi/abs/10.1089/thy.2011.0526 CrossRefPubMed

14.

Gadiraju S, Lee CJ, Cooper DS. Levothyroxine dosing following bariatric surgery. Obes Surg. 2016;26(10):2538–42. Available from: https://doi.org/10.1007/s11695-016-2314-x CrossRefPubMed

15.

Sawaya RA, Jaffe J, Friedenberg L, et al. Vitamin, mineral, and drug absorption following bariatric surgery. Curr Drug Metab. 2012;13(9):1345–55. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3571763&tool=pmcentrez&rendertype=abstract CrossRefPubMedPubMedCentral

16.

Smith A, Henriksen B, Cohen A. Pharmacokinetic considerations in Roux-en-Y gastric bypass patients. Am J Health Syst Pharm. 2011;68(23):2241–7.CrossRefPubMed

17.

Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988–1028. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23246686 CrossRefPubMed

18.

Fierabracci P, Martinelli S, Tamberi A, et al. Weight loss and variation of levothyroxine requirements in hypothyroid obese patients after bariatric surgery. Thyroid. 2016;26(4):499–503. Available from: http://online.liebertpub.com/doi/10.1089/thy.2015.0473 CrossRefPubMed

19.

Orlander PR. Hypothyroidism [Internet]. Medscape. 2018. Available from: https://emedicine.medscape.com/article/122393-overview.

20.

Liel Y, Harman-boehm I, Unit E, et al. Evidence for a clinically importante adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients. J Clin Endocrinol Metab. 1996;81(2):1–3.

21.

Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781–92. Available from: https://doi.org/10.1016/j.beem.2009.06.006 CrossRefPubMed

22.

Ionut V, Bergman RN. Mechanisms responsible for excess weight loss after bariatric surgery. J Diabetes Sci Technol. 2011;5(5):1263–82.CrossRefPubMedPubMedCentral

23.

Ochner CN, Gibson C, Shanik M, et al. Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes. 2011;35(2):153–66.CrossRef

24.

Miras AD, Le Roux CW. Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2013;10(10):575–84. Available from: https://doi.org/10.1038/nrgastro.2013.119 CrossRefPubMed

25.

Aggarwal S, Modi S, Jose T. Laparoscopic sleeve gastrectomy leads to reduction in thyroxine requirement in morbidly obese patients with hypothyroidism. World J Surg. 2014;38(10):2628–31.CrossRefPubMed

26.

Sundaram U, McBride C, Shostrom V, et al. Prevalence of preoperative hypothyroidism in bariatric surgery patients and postoperative change in thyroid hormone requirements. Bariatric Surgical Practice and Patient Care. 2013;8(4):147–51. Available from: http://online.liebertpub.com/doi/10.1089/bari.2013.0006 CrossRef

27.

Azizi F, Belur R, Albano J. Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Ann Intern Med. 1979;90(6):941–2.CrossRefPubMed

28.

Bevan JS, Munro J. Thyroxine malabsorption following intestinal bypass surgery. Int J Obes. 1986;10(3):245–6.PubMed

29.

Topliss DJ, Wright JA, Volpe R. Increased requirement for thyroid hormone after a jejunoileal bypass operation. Can Med Assoc J. 1980;123(8):765–6.PubMedPubMedCentral

30.

Santini F, Pinchera A, Marsili A, et al. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab. 2005;90(1):124–7. Available from: http://press.endocrine.org/doi/10.1210/jc.2004-1306 CrossRefPubMed

31.

Nimmo WS. Drugs, diseases and altered gastric emptying. Clin Pharmacokinet. 1976;1(3):189–203.CrossRefPubMed

32.

Joon Kim P, Sachmechi I. Levothyroxine malabsorption induced by diabetic gastroparesis exacerbated during pregnancies: effect of intramuscular levothyroxine injections and levothyroxine soft gel capsules. AACE Clinical Case Reports. 2015;1(1):73–8.CrossRef

33.

Skelin M, Lucijanić T, Amidžić Klarić D, et al. Factors affecting gastrointestinal absorption of levothyroxine: a review. Clin Ther. 2017;39(2):378–403.CrossRefPubMed

34.

Quercia I, Dutia R, Kotler DP, et al. Gastrointestinal changes after bariatric surgery. Diabetes Metab. 2014;40(2):87–94. https://doi.org/10.1016/j.diabet.2013.11.003.CrossRef

35.

Burton PR, Yap K, Brown WA, et al. Effects of adjustable gastric bands on gastric emptying, supra- and infraband transit and satiety: a randomized double-blind crossover trial using a new technique of band visualization. Obes Surg. 2010;20(12):1690–7.CrossRefPubMed

Title: The Effect of the Bariatric Surgery Type on the Levothyroxine Dose of Morbidly Obese Hypothyroid Patients
Authors: Jorge Pedro
Filipe Cunha
Pedro Souteiro
João Sérgio Neves
Vanessa Guerreiro
Daniela Magalhães
Rita Bettencourt-Silva
Sofia Castro Oliveira
Maria Manuel Costa
Joana Queirós
Paula Freitas
Ana Varela
Davide Carvalho
Publication date: 01-11-2018
Publisher: Springer US
Published in: Obesity Surgery / Issue 11/2018
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-018-3388-4

At a glance: The STEP trials

Springer Medicine

The Effect of the Bariatric Surgery Type on the Levothyroxine Dose of Morbidly Obese Hypothyroid Patients

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2018

Bariatric Surgery in Patients with Cirrhosis and Portal Hypertension

Calibration of the Gastric Pouch in Laparoscopic Roux-en-Y Gastric Bypass: Does It Matter? The Influence on Weight Loss

No Difference in Ghrelin-Producing Cell Expression in Obese Versus Non-obese Stomach: a Prospective Histopathological Case-Control Study

Use of Opioid Analgesics Before and After Gastric Bypass Surgery in Sweden: a Population-Based Study

Association of Maternal Roux-en-Y Gastric Bypass with Obstetric Outcomes and Fluid Intelligence in Offspring

The Efficacy of Energy-Restricted Diets in Achieving Preoperative Weight Loss for Bariatric Patients: a Systematic Review